(NASDAQ: PGNY) Progyny's forecast annual revenue growth rate of 18.44% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.05%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.76%.
Progyny's revenue in 2024 is $1,108,282,000.On average, 5 Wall Street analysts forecast PGNY's revenue for 2024 to be $123,742,331,118, with the lowest PGNY revenue forecast at $123,239,375,444, and the highest PGNY revenue forecast at $124,748,623,349. On average, 5 Wall Street analysts forecast PGNY's revenue for 2025 to be $148,318,028,925, with the lowest PGNY revenue forecast at $145,735,262,984, and the highest PGNY revenue forecast at $151,486,592,539.
In 2026, PGNY is forecast to generate $175,970,878,486 in revenue, with the lowest revenue forecast at $169,250,964,092 and the highest revenue forecast at $182,461,882,346.